Related Experiment Videos
Evidence for a lower target blood pressure for people with heart disease
Clive Rosendorff1, Henry R Black
1Mount Sinai School of Medicine, New York, New York, USA. clive.rosendorff@va.gov
Insights
Lowering blood pressure (BP) targets in hypertension management shows potential benefits. Current evidence suggests aggressive BP treatment is not harmful and may be beneficial, though more research is needed.
Area of Science:
- Cardiology
- Nephrology
- Vascular Medicine
Background:
- Current hypertension guidelines recommend a blood pressure (BP) target below 140/90 mmHg for all patients.
- Lower BP targets (below 130/80 mmHg) are recommended for patients with diabetes, chronic kidney disease, coronary artery disease, and high cardiovascular risk (Framingham Risk Score ≥10%).
Purpose of the Study:
- To review the evidence supporting the benefits of lower blood pressure targets in managing hypertension.
- To evaluate the safety and efficacy of more aggressive blood pressure reduction strategies.
Main Methods:
- Review of animal studies, clinical trials (surrogate and hard endpoints), and epidemiologic data.
- Assessment of theoretical concerns regarding a J-shaped curve and myocardial ischemia risk with lower diastolic BP targets.
Main Results:
- Evidence suggests that the theoretical risk associated with a J-shaped curve is not a significant concern.
- Animal studies, clinical trials, and epidemiological data provide support against the risks of lowering BP aggressively.
- Indirect evidence indicates potential benefits of lower BP targets.
Conclusions:
- There is currently no evidence to suggest that more aggressive blood pressure treatment is harmful.
- Substantial indirect evidence supports the potential benefits of lower blood pressure targets in hypertension management.
- Clinical trials specifically designed to address the benefits of lower BP targets are ongoing.
Purpose Of Review:
The review assesses the evidence for the benefit of lower blood pressure (BP) targets in hypertension management.
Recent Findings:
The current consensus target for the treatment of hypertension is a BP of below 140/90 mmHg for all patients, and a BP of below 130/80 mmHg for those with diabetes or chronic kidney disease. Recently added to the list of conditions warranting the lower BP target are coronary artery disease and coronary artery disease equivalents (stroke, carotid disease, aortic aneurysm, and peripheral vascular disease), as well as those individuals with a Framingham Risk Score of at least 10%. One theoretical issue with lower BP targets may be the existence of a J-shaped curve of BP versus cardiovascular event rate, implying a greater risk, especially of myocardial ischemia, of lowering diastolic BP, which is also the filling pressure of the coronary arteries, below the lower limit of coronary autoregulation. The evidence that this is not a compelling concern is provided by animal studies, clinical trials with both surrogate and hard endpoints, and epidemiologic data.
Summary:
There is at present no proof that more aggressive treatment is harmful and much indirect evidence that it may be beneficial, although the clinical trials that specifically address this question are still in progress.
Related Concept Videos
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Atherosclerosis III: Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease IV: Preventive Measures